Recently, a group of women who had previously filed cancer cases against Johnson & Johnson (J&J) took a significant step by filing a class action lawsuit. The lawsuit targets J&J and several of its top executives, alleging fraudulent transfer related to manipulative bankruptcy tactics. These women are represented by several plaintiff law firms that have been vocally opposing J&J’s bankruptcy strategy.

J&J responded swiftly, stating it will “immediately” seek to dismiss the lawsuit. Erik Hass of J&J defended their bankruptcy filing, claiming the company has “offered one of the largest resolutions in the history of mass tort litigation.” However, this statement seems to overlook the more than 60,000 cases filed by plaintiffs suffering from severe injuries, including ovarian cancer.

A recent study by the National Institutes of Health, published in the Journal of Clinical Oncology, supports the claims against J&J. The study found a correlation between the genital use of talc powder and ovarian cancer, especially with frequent or prolonged use. This new evidence could influence the ongoing legal battles and the upcoming bankruptcy proceedings.

Subscribe Now!

Get exclusive updates on the hottest trending torts by signing up for DemandLane newsletter!

By signing up you’re also agreeing to our Privacy Policy

By clicking the “Submit” Button, you consent to be called/texted at the number provided above by Demandlane. These calls/texts may be delivered via automated technology.